+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Real-Time PCR Devices Market by Technology Innovation, Device Type, End User Industry, Application Field, Instrument Capability, Pricing Tier, Innovation Strategy - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6159587
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Real-time polymerase chain reaction (PCR) has revolutionized molecular diagnostics by enabling rapid, precise quantification of nucleic acids. As pathogens evolve and applications expand beyond clinical diagnostics into agriculture, food safety, and environmental monitoring, the demand for sophisticated real-time PCR devices has surged. Technological innovations in thermal cycling, optical detection, and microfluidic integration have propelled instrument performance, accessibility, and affordability.

In this dynamic environment, laboratory managers, biotech entrepreneurs, and public health officials must understand the core drivers shaping adoption and investment. Enhanced thermal cycling efficiency has reduced turnaround times, while advances in optical detection sensitivity-both CCD-based and photodiode-based systems-have improved assay accuracy. At the same time, the integration of rapid heat exchange mechanisms and multiplex testing capabilities is redefining throughput and workflow automation.

Against this backdrop, this executive summary offers an authoritative overview of key market transformations, the implications of recent trade measures, segmentation insights, regional dynamics, and leading competitive developments. By synthesizing these elements, decision-makers can pinpoint strategic opportunities for innovation, investment, and partnership in the evolving real-time PCR landscape.

Section 2: Transformative Shifts Reshaping Real-Time PCR Technology

The real-time PCR market is witnessing transformative shifts driven by convergence of technological breakthroughs and evolving end-user requirements. First, microfluidic integration has miniaturized reaction volumes and slashed reagent consumption, enabling point-of-care instruments to deliver laboratory-grade results in clinics and field settings. Second, optical detection is transitioning from CCD-based systems to more compact photodiode arrays, enhancing portability without sacrificing sensitivity.

Simultaneously, innovation in thermal cycling-particularly rapid heat exchange technologies-has accelerated amplification cycles, reducing analysis times from hours to under thirty minutes. This shift is critical for applications such as pathogen detection during outbreaks and time-sensitive gene expression studies. Third, the rise of wireless connectivity and advanced software integration is transforming data management, facilitating seamless remote monitoring and real-time analytics within automated workflows.

Finally, the proliferation of multiplex testing platforms has expanded the spectrum of simultaneous assays, catering to genomic, transcriptomic, and epigenetic analyses. As a result, real-time PCR devices are no longer viewed solely as standalone instruments but as integrated components of broader laboratory ecosystems. These transformative shifts are redefining performance benchmarks and reshaping procurement decisions across academia, diagnostics, agriculture, and biotechnology.

Section 3: Cumulative Impact of United States Tariffs 2025 on Supply and Costs

The implementation of new United States tariffs in 2025 has introduced both challenges and strategic recalibrations across the real-time PCR supply chain. Increased import duties on key components-such as precision optics, thermal modules, and microfluidic chips-have elevated production costs for many global manufacturers. As a result, organizations are evaluating alternative sourcing strategies, including domestic component partnerships and in-country assembly operations.

In response, several device makers have initiated dual-sourcing agreements to mitigate cost pressures and ensure continuity of supply. Additionally, some companies are accelerating investments in local manufacturing facilities to circumvent tariff exposure and deliver regionally optimized solutions. For end users, these shifts have translated into marginal increases in device pricing, prompting laboratory directors and procurement teams to seek instruments that balance performance and total cost of ownership.

Despite these headwinds, tariff-induced disruptions have spurred innovation in component reuse and circular manufacturing approaches. By redesigning optics modules for modular interchangeability and standardizing thermal block interfaces, suppliers are reducing dependency on tariff-impacted parts. This resilience ensures that advanced real-time PCR capabilities remain accessible to diverse end-user segments, from high-throughput pharmaceutical screening to decentralized point-of-care testing.

Section 4: Key Segmentation Insights Across Technologies, Users, and Applications

Insight into market segmentation reveals the multifaceted nature of real-time PCR device requirements. Based on technology innovation, the market encompasses microfluidic integration for reduced reagent volumes, optical detection platforms classified as CCD-based or photodiode-based systems, and thermal cycling efficiency advancements such as rapid heat exchange modules. In terms of device type, conventional bench-top instruments coexist with lab-on-chip, portable, and point-of-care solutions, each tailored to specific throughput and mobility needs.

Focusing on end-user industries highlights applications ranging from academic and research institutions exploring gene expression profiles to agricultural and veterinary sectors monitoring pathogen spread. Clinical diagnostics laboratories demand high-throughput, automated workflows, while food safety and environmental agencies prioritize rapid, on-site pathogen detection. Pharmaceutical and biotechnology companies require multiplex testing and real-time data analysis to streamline drug development pipelines.

Diverse application fields underscore the range of assays supporting copy number variation, drug development, gene expression, genotyping, methylation analysis, and pathogen detection. Instrument capabilities vary accordingly, with automated workflow systems enhancing operational efficiency, high-throughput platforms catering to large-scale screening, multiplex testing devices enabling simultaneous target detection, and real-time data analysis tools offering actionable insights. Pricing tiers span entry-level devices designed for teaching labs to high-end instruments engineered for core facilities, with mid-tier options striking a balance of cost and capability. Finally, innovation strategies such as advanced software integration, customizable modules, and wireless connectivity drive differentiation across vendor offerings.

Section 5: Key Regional Insights and Growth Drivers

Regional dynamics reveal divergent growth drivers and priorities across the Americas, Europe, Middle East & Africa (EMEA), and Asia-Pacific. In the Americas, strong investment in clinical diagnostics and public health infrastructure fuels demand for high-throughput bench-top systems and automated workflows, particularly amid ongoing efforts to modernize laboratory capacity in both developed and emerging markets.

Within EMEA, regulatory harmonization and collaborative research initiatives are accelerating adoption of lab-on-chip and point-of-care devices. This region’s focus on food safety and environmental monitoring also drives investments in portable PCR units capable of field-based pathogen detection. Meanwhile, Asia-Pacific’s rapidly expanding biotechnology sector and agricultural genomics market create fertile ground for versatile, cost-effective instruments. Manufacturers are leveraging local partnerships and regional manufacturing hubs to meet price-sensitive requirements and comply with evolving import regulations.

Across all regions, there is a unified emphasis on flexible instrument platforms that support multiplex testing, real-time data analysis, and seamless integration with laboratory information management systems. These regional nuances underscore the importance of tailoring go-to-market strategies to address specific regulatory landscapes, end-user priorities, and budgetary constraints.

Section 6: Key Company Insights and Competitive Strategies

Competitive analysis of leading companies in the real-time PCR space reveals diverse strategic approaches. Abbott Molecular Inc. and Roche Diagnostics GmbH emphasize turnkey clinical solutions with robust service networks, while Bio-Rad Laboratories, Inc. and Thermo Fisher Scientific Inc. focus on broad instrument portfolios and software-driven workflow optimization. Agilent Technologies, Inc. and Illumina, Inc. are investing in microfluidic and sequencing-integrated platforms to capture cross-technology synergies.

Cepheid, Inc. and BioFire Diagnostics, LLC lead in point-of-care cartridge-based systems, targeting rapid pathogen detection, whereas Qiagen N.V. and Promega Corporation leverage their reagent expertise to drive instrument-consumable lock-in. Shimadzu Corporation and PerkinElmer, Inc. differentiate through advanced thermal cycling modules and customizable hardware interfaces. Emerging players such as Bioneer Corporation, GenDx B.V., and OptiGene Limited are carving niches with specialized applications in methylation analysis and genotyping.

Companies like Luminex Corporation and Meridian Bioscience, Inc. enhance multiplex testing capabilities, while Integrated DNA Technologies and Eurofins Technologies are expanding service-oriented offerings that couple sequencing and PCR workflows. Strategic moves by Da An Gene Ltd., Seegene Inc., and Altona Diagnostics GmbH focus on regional manufacturing expansion to navigate tariff challenges. Collectively, these firms shape a competitive landscape marked by continuous innovation in software integration, wireless connectivity, and modular instrument design.

Section 7: Actionable Recommendations for Industry Leaders

Industry leaders can capitalize on current dynamics by pursuing targeted strategies. First, invest in modular device architectures that allow rapid integration of new detection chemistries and thermal cycling enhancements, thereby extending product lifecycles and reducing R&D costs. Second, establish strategic partnerships with component suppliers in tariff-exposed regions to secure dual-sourcing agreements and local manufacturing capabilities.

Third, differentiate through software-driven value adds such as intuitive user interfaces, cloud-based analytics, and AI-powered assay optimization. Fourth, expand service portfolios by offering end-to-end solutions-from sample preparation to data interpretation-to foster customer loyalty and recurring revenue streams. Fifth, tailor go-to-market approaches to regional priorities: focus on high-throughput automation in the Americas, point-of-care agility in EMEA, and cost-sensitive, scalable platforms in Asia-Pacific.

Finally, embrace sustainable practices by designing reusable modules and reducing plastic waste in consumables. This commitment to environmental stewardship will resonate with regulators and end users alike, while reinforcing brand reputation in an increasingly eco-conscious marketplace.

Section 8: Conclusion on Navigating the Evolving Real-Time PCR Market

Real-time PCR devices occupy a critical nexus between molecular biology innovation and practical diagnostics. The interplay of advanced thermal cycling technologies, versatile optical detection methods, and integrated microfluidics has reshaped expectations for speed, sensitivity, and scalability. Concurrently, regulatory shifts and tariff pressures have tested supply chain resilience, underscoring the importance of strategic partnerships and local manufacturing.

Segmentation analysis highlights the breadth of market opportunities-from academic research and pharmaceutical screening to agricultural surveillance and food safety testing. Regional nuances further refine market entry tactics and product positioning. Leading companies are responding with modular designs, software-centric workflows, and sustainable practices that meet evolving end-user demands.

As stakeholders navigate this complex landscape, a clear focus on innovation, operational agility, and customer-centric solutions will determine market leadership. By aligning product development with regional needs and embracing flexible business models, organizations can sustain growth and drive meaningful impact in the era of precision diagnostics.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology Innovation
    • Microfluidic Integration
    • Optical Detection
      • Ccd Based
      • Photodiode Based
    • Thermal Cycling Efficiency
      • Rapid Heat Exchange
  • Device Type
    • Conventional Instruments
    • Lab On Chip Instruments
    • Point Of Care Instruments
    • Portable Instruments
  • End User Industry
    • Academic and Research
    • Agriculture and Veterinary Medicine
    • Clinical Diagnostics
    • Food Safety and Environment
    • Pharmaceutical and Biotechnology
  • Application Field
    • Copy Number Variation
    • Drug Development
    • Gene Expression
    • Genotyping
    • Methylation Analysis
    • Pathogen Detection
  • Instrument Capability
    • Automated Workflow
    • High Throughput Systems
    • Multiplex Testing
    • Real Time Data Analysis
  • Pricing Tier
    • Entry Level Devices
    • High End Devices
    • Mid Tier Devices
  • Innovation Strategy
    • Advanced Software Integration
    • Customizable Module
    • Wireless Connectivity
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Abbott Molecular Inc.
  • Agilent Technologies, Inc.
  • Altona Diagnostics GmbH
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • BioFire Diagnostics, LLC
  • BioMérieux S.A.
  • Bioneer Corporation
  • BioSewoom Co., Ltd.
  • Cepheid, Inc.
  • Da An Gene Ltd.
  • Eurofins Technologies
  • Fluidigm Corporation
  • GenDx B.V.
  • GenMark Diagnostics, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies
  • Luminex Corporation
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Norgen Biotek Corporation
  • OptiGene Limited
  • Paragon Biosciences, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Roche Diagnostics GmbH
  • Seegene Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Real-Time PCR Devices Market, by Technology Innovation
8.1. Introduction
8.2. Microfluidic Integration
8.3. Optical Detection
8.3.1. Ccd Based
8.3.2. Photodiode Based
8.4. Thermal Cycling Efficiency
8.4.1. Rapid Heat Exchange
9. Real-Time PCR Devices Market, by Device Type
9.1. Introduction
9.2. Conventional Instruments
9.3. Lab On Chip Instruments
9.4. Point Of Care Instruments
9.5. Portable Instruments
10. Real-Time PCR Devices Market, by End User Industry
10.1. Introduction
10.2. Academic And Research
10.3. Agriculture And Veterinary Medicine
10.4. Clinical Diagnostics
10.5. Food Safety And Environment
10.6. Pharmaceutical And Biotechnology
11. Real-Time PCR Devices Market, by Application Field
11.1. Introduction
11.2. Copy Number Variation
11.3. Drug Development
11.4. Gene Expression
11.5. Genotyping
11.6. Methylation Analysis
11.7. Pathogen Detection
12. Real-Time PCR Devices Market, by Instrument Capability
12.1. Introduction
12.2. Automated Workflow
12.3. High Throughput Systems
12.4. Multiplex Testing
12.5. Real Time Data Analysis
13. Real-Time PCR Devices Market, by Pricing Tier
13.1. Introduction
13.2. Entry Level Devices
13.3. High End Devices
13.4. Mid Tier Devices
14. Real-Time PCR Devices Market, by Innovation Strategy
14.1. Introduction
14.2. Advanced Software Integration
14.3. Customizable Module
14.4. Wireless Connectivity
15. Americas Real-Time PCR Devices Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Real-Time PCR Devices Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Real-Time PCR Devices Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Molecular Inc.
18.3.2. Agilent Technologies, Inc.
18.3.3. Altona Diagnostics GmbH
18.3.4. Becton, Dickinson & Company
18.3.5. Bio-Rad Laboratories, Inc.
18.3.6. BioFire Diagnostics, LLC
18.3.7. BioMérieux S.A.
18.3.8. Bioneer Corporation
18.3.9. BioSewoom Co., Ltd.
18.3.10. Cepheid, Inc.
18.3.11. Da An Gene Ltd.
18.3.12. Eurofins Technologies
18.3.13. Fluidigm Corporation
18.3.14. GenDx B.V.
18.3.15. GenMark Diagnostics, Inc.
18.3.16. Illumina, Inc.
18.3.17. Integrated DNA Technologies
18.3.18. Luminex Corporation
18.3.19. Merck KGaA
18.3.20. Meridian Bioscience, Inc.
18.3.21. Norgen Biotek Corporation
18.3.22. OptiGene Limited
18.3.23. Paragon Biosciences, Inc.
18.3.24. PerkinElmer, Inc.
18.3.25. Promega Corporation
18.3.26. Qiagen N.V.
18.3.27. Roche Diagnostics GmbH
18.3.28. Seegene Inc.
18.3.29. Shimadzu Corporation
18.3.30. Thermo Fisher Scientific Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. REAL-TIME PCR DEVICES MARKET MULTI-CURRENCY
FIGURE 2. REAL-TIME PCR DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. REAL-TIME PCR DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2024 VS 2030 (%)
FIGURE 14. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. REAL-TIME PCR DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. REAL-TIME PCR DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. REAL-TIME PCR DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY MICROFLUIDIC INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY CCD BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY PHOTODIODE BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY RAPID HEAT EXCHANGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY CONVENTIONAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY LAB ON CHIP INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY PORTABLE INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY AGRICULTURE AND VETERINARY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY FOOD SAFETY AND ENVIRONMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY COPY NUMBER VARIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY GENOTYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY METHYLATION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY AUTOMATED WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY HIGH THROUGHPUT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY MULTIPLEX TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY REAL TIME DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY ENTRY LEVEL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY HIGH END DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY MID TIER DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY ADVANCED SOFTWARE INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY CUSTOMIZABLE MODULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL REAL-TIME PCR DEVICES MARKET SIZE, BY WIRELESS CONNECTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 74. CANADA REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 76. CANADA REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 77. CANADA REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 79. CANADA REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 80. CANADA REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 81. CANADA REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 82. CANADA REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 83. MEXICO REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 86. MEXICO REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 88. MEXICO REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 89. MEXICO REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 90. MEXICO REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES REAL-TIME PCR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 121. CHINA REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 122. CHINA REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 123. CHINA REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 124. CHINA REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 125. CHINA REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 126. CHINA REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 127. CHINA REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 128. CHINA REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 129. CHINA REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 130. INDIA REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 131. INDIA REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 132. INDIA REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 133. INDIA REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 134. INDIA REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 135. INDIA REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 136. INDIA REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 137. INDIA REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 138. INDIA REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 148. JAPAN REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 149. JAPAN REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 150. JAPAN REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 151. JAPAN REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 152. JAPAN REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 153. JAPAN REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 154. JAPAN REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 155. JAPAN REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 156. JAPAN REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 200. TAIWAN REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 202. THAILAND REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 203. THAILAND REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 204. THAILAND REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 205. THAILAND REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 206. THAILAND REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 207. THAILAND REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 208. THAILAND REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 209. THAILAND REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 210. THAILAND REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 218. VIETNAM REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 219. VIETNAM REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 230. DENMARK REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 231. DENMARK REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 232. DENMARK REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 233. DENMARK REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 234. DENMARK REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 235. DENMARK REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 236. DENMARK REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 237. DENMARK REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 238. DENMARK REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 239. EGYPT REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 240. EGYPT REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 241. EGYPT REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 242. EGYPT REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 243. EGYPT REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 244. EGYPT REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 245. EGYPT REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 246. EGYPT REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 247. EGYPT REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 248. FINLAND REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 249. FINLAND REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 250. FINLAND REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 251. FINLAND REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 252. FINLAND REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 253. FINLAND REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 254. FINLAND REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 255. FINLAND REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 256. FINLAND REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 257. FRANCE REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 258. FRANCE REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 259. FRANCE REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 260. FRANCE REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 261. FRANCE REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 262. FRANCE REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 263. FRANCE REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 264. FRANCE REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 265. FRANCE REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 266. GERMANY REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 267. GERMANY REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 268. GERMANY REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 269. GERMANY REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 270. GERMANY REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 271. GERMANY REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 272. GERMANY REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 273. GERMANY REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 274. GERMANY REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 284. ITALY REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 285. ITALY REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 286. ITALY REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 287. ITALY REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 288. ITALY REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 289. ITALY REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 290. ITALY REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 291. ITALY REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 292. ITALY REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 311. NORWAY REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
TABLE 312. NORWAY REAL-TIME PCR DEVICES MARKET SIZE, BY OPTICAL DETECTION, 2018-2030 (USD MILLION)
TABLE 313. NORWAY REAL-TIME PCR DEVICES MARKET SIZE, BY THERMAL CYCLING EFFICIENCY, 2018-2030 (USD MILLION)
TABLE 314. NORWAY REAL-TIME PCR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 315. NORWAY REAL-TIME PCR DEVICES MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 316. NORWAY REAL-TIME PCR DEVICES MARKET SIZE, BY APPLICATION FIELD, 2018-2030 (USD MILLION)
TABLE 317. NORWAY REAL-TIME PCR DEVICES MARKET SIZE, BY INSTRUMENT CAPABILITY, 2018-2030 (USD MILLION)
TABLE 318. NORWAY REAL-TIME PCR DEVICES MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 319. NORWAY REAL-TIME PCR DEVICES MARKET SIZE, BY INNOVATION STRATEGY, 2018-2030 (USD MILLION)
TABLE 320. POLAND REAL-TIME PCR DEVICES MARKET SIZE, BY TECHNOLOGY INNOVATION, 2018-2030 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Real-Time PCR Devices market report include:
  • Abbott Molecular Inc.
  • Agilent Technologies, Inc.
  • Altona Diagnostics GmbH
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • BioFire Diagnostics, LLC
  • BioMérieux S.A.
  • Bioneer Corporation
  • BioSewoom Co., Ltd.
  • Cepheid, Inc.
  • Da An Gene Ltd.
  • Eurofins Technologies
  • Fluidigm Corporation
  • GenDx B.V.
  • GenMark Diagnostics, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies
  • Luminex Corporation
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Norgen Biotek Corporation
  • OptiGene Limited
  • Paragon Biosciences, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Roche Diagnostics GmbH
  • Seegene Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.